Nasdaq
TGTX
TG Therapeutics, Inc.
- Health Care
- 1 day
- −0.7%
- 1 month
- −14.7%
- 1 year
- +78.9%
$49.55 · Mkt cap $7.59B · P/E 17.89
At the 6 Aug 2026 close
Nasdaq
TG Therapeutics, Inc.
$49.55 · Mkt cap $7.59B · P/E 17.89
At the 6 Aug 2026 close
TG Therapeutics, Inc. trades under the ticker TGTX on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $7.59B. The last closing price was $49.55, on 6 Aug 2026. It trades at 17.89 times its last reported annual diluted earnings per share. Over the past year the share price is +78.9%, and −14.7% over the past month. Returns are price returns and exclude dividends.
This page exists because TGTX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.